NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
Goldline Pharmaceutical

Goldline Pharmaceutical

IPO
Issue: 11.61 CrPrice: ₹ 41.00
View Details

Goldline Pharmaceutical IPO Allotment Date Finalised for Today

The allotment date for the initial public offering (IPO) of Goldline Pharmaceutical Ltd has been finalised for today, Friday, 15 May. Investors who applied for the issue can check the allotment status on the registrar's portal, Bigshare Services Pvt Ltd. The company's IPO subscription status on the third day of bidding was 840.74 times, as per chittorgarh.com.

IPO StatusSubscription Period
Subscription Status840.74 times
Subscription Period12 - 14 May

The subscription period for the IPO opened on Tuesday, 12 May and ended on Thursday, 14 May. Investors can review the allocation information to see how many shares have been assigned to them, if applicable. The allocated shares will be visible in the IPO allocation status. Applicants who did not receive any shares will initiate the refund process.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

The assigned shares will be credited to their demat accounts. Individuals who received shares will have their demat accounts credited on Monday, 18 May. The refund procedure will also begin on Monday. The Goldline Pharmaceutical IPO listing date is fixed for Tuesday, 19 May on BSE SME.

Goldline Pharmaceutical IPO Grey Market Premium (GMP) is currently at +15. Considering the upper end of the IPO price band and the current GMP, the estimated listing price of Goldline Pharmaceutical shares is ₹58 apiece, which is 34.88% lower than the IPO price of ₹43. Based on grey-market activity observed over the last 9 sessions, today's IPO GMP shows an upward trend and is expected to have a robust listing.

Checking Goldline Pharmaceutical IPO Allotment Status

To check the allotment status, investors can follow these steps:

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

  1. Visit the Bigshare website at https://ipo.bigshareonline.com/ipo_status.html.
  2. Select "Goldline Pharmaceutical IPO" from the available options.
  3. Choose either "PAN Number, Beneficiary ID, or Application No./CAF No."
  4. Click on "Search" to view the allotment status.

Alternatively, investors can also check the allotment status on the BSE website:

  1. Visit the allotment section on the official BSE site at https://www.bseindia.com/investors/appli_check.aspx.
  2. Pick 'Equity' from the options listed under 'Issue Type.'
  3. Select the 'Issue Name' from the dropdown list and indicate the specific IPO.
  4. Enter your application number or PAN.

Investor Takeaway

Investors can check their Goldline Pharmaceutical IPO allotment status on the registrar's portal.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.